PAX6 is a DNA-binding transcription factor that has been implicated in the fundamental 91 regulation of the development of the cerebral cortex 30, 31 . Mutations in PAX6 are most 92 commonly associated with aberrations in eye development, but studies have demonstrated 93 that mutations in PAX6 can also be associated with neurological and psychiatric conditions 32 . 94
Although PAX6 has long been studied from a genetic point of view, relatively little is known 95 of the mechanisms underlying its function. It has been shown to act as a transcriptional 96 activator, and in this role associated with H3K4me3 methyl transferases 33 . However, there 97 are further reports of PAX6 preferentially binding to methylated DNA 34 , and when Pax6 is 98 ablated, the expression of a subset of genes has been shown to be increased 35 . Indeed, it has 99 recently been reported that PAX6 can interact with class I HDACs, specifically HDAC1, 100
suggesting that PAX6 may mediate direct repression of transcription 36 . The increased gene 101 expression could however theoretically be explained by a lack of activation of a secondary 102 repressor, the association with binding to methylated DNA could be mere association, and 103 HDAC1 is not ubiquitously expressed in neural progenitors 11 . There is thus a need for 104 increased understanding of putative mechanisms underlying Pax6 function as a 105 transcriptional repressor. 106
107
The aim of this study was to analyze Pax6 occupancy patterns and compare these to 108
H3K4me3 levels and binding of the H3K4 demethylase KDM5C. Combining chromatin 109 immunoprecipitation (ChIP) assays with sequencing (ChIP-Seq) is a powerful method to 110 identify genome-wide DNA binding sites for transcription factors and other proteins. To this 111 end we have downloaded and analysed two published ChIP-seq data sets 37,38 . While we 112 found a subset of Pax6 peaks coinciding with H3K4me3-positive regions, most Pax6 binding 113 was detected in regions with low H3K4me3 (H3K4me3-). Indeed, transcriptional assays 114 showed that PAX6 could act as a direct repressor of transcription, and this repression was 115 associated with a small but reproducible decrease in H3K4me3 levels. Analysis of the 116 occupancy of KDM5C at regions with high and low levels of H3K4me3 revealed that KDM5C 117 occupied H3K4me3-positive loci at a majority of peaks, but as expected, a large number of 118 the KDM5C-occupied regions were H3K4me3-. We therefore made a comparison of all three 119 datasets and found 177 peaks on 131 genes where Pax6 and KDM5C overlapped with genes, we found a number of genes associated with Notch signaling, including Dll1, Dll4, and 122 When combining the two datasets, we found 1,735 overlapping peaks between Pax6 and 153 H3K4me3 (Figure 1a ). This confirms previous observations of Pax6 association with 154
H3K4me3 methyl transferases 33 . The number of overlapping peaks was however lower than 155 expected and the vast majority of Pax6-positive peaks were associated with H3K4me3-156 negative (H3K4me3-) regions (Figure 1a The analysis of PAX6 occupancy in combination with H3K4me3-negative regions prompted 164 us to investigate whether PAX6 could act directly as a repressor in transcriptional assays. We 165 first constructed a Gal4-PAX6 fusion construct that could be used in a doxycycline (DOX) 166 sensitive assay (DOX-on) 41 (Supplementary figure 1) , and analyzed its activation of a UAS-167 promoter in a luciferase reporter context in stably transfected HEK293 cells. This assay 168 revealed that PAX6 indeed can act as a direct transcriptional repressor (Figure 1d ) 169 (p=0.0008), in accordance with recent observations 36 . 170
171
We next utilized the DOX-on system to investigate the effects on chromatin modifications on 172 the stably transfected promoter (Figure 1e ). We analyzed three of the most well-studied 173 lysine modifications, i.e. H3K4me3, acetylation of lysine 9 on histone H3 (H3K9ac) and 174 acetylation of lysine 27 on histone H3 (H3K27ac). Whereas H3K9ac did not decrease, we 175 found a reproducible decrease of H3K27ac by activation of Gal4-PAX6 in this assay ( Figure  176 1e). This is in accordance with the recent observations linking PAX6 to class I HDACs such as 177 HDAC1 36 . 178 179 Importantly, we found a small but reproducible Gal4-PAX6-mediated decrease in H3K4me3 180 levels in this assay (Figure 1e ). This result suggests that PAX6 may act as a transcriptional 181 repressor at least in part by recruiting an H3K4me3 demethylase. 182 183 184 KDM5C occupancy is found both on H3K4me3-positive and -negative genes 185
186
As the results from the transcriptional assays suggested that Pax6 could be acting as a 187
repressor of transcription at least in part by bringing in H3K4me3 demethylase activity, we 188 pursued additional in silico analysis of KDM5C, the most prevalent H3K4 demethylase in the 189 developing nervous system cells 42 . This analysis revealed 7,715 KDM5C peaks (Figure 2a) in 190 neurons isolated from E16.5 mouse embryonic cortices and harvested after 10 days in vitro 191 culture 37 , and further analysis of the most significant Reactome terms demonstrated that 192 the most pivotal class of genes occupied by KDM5C was associated with neuronal systems 193 (over represented p-value 3.25E-12) (Figure 2b) . 194
195 Surprisingly, we found that 4,350 KDM5C peaks overlapped with the H3K4me3-positive 196 regions detected from the embryonic forebrain ChIP-Seq (Figure 2a ). This is interesting due 197 to the presumed H3K4 demethylase activity of KDM5C. Nevertheless, the analysis revealed 198 that 3,365 KDM5C peaks were associated with low H3K4me3 levels (Figure 2a to be present on H3K4me3-positive regions (Figure 3a) . Most interesting in the context of 210 the present study was however the genes that were co-occupied by Pax6 and KDM5C on 211 regions with low H3K4me3. Here we discovered a subset of 177 peaks on 131 different 212 genes that were co-occupied by Pax6 and KDM5C on H3K4me3-regions. 213
214
When analyzing the biological function associated with the overlapping peaks using the 215 Reactome terms, we made the intriguing finding that a substantial part of these 131 genes 216
were associated with Notch signaling pathway (Figure 3b) We next analyzed the Pax6/KDM5C/H3K4me3-peaks in detail on specific genes involved in 227
Notch signaling. DLL1 is a ligand of the Notch receptor, and its gene was found to contain 228 multiple PAX6 peaks of which one overlapped with KDM5C (Figure 4a) . The Pax6/KDM5C-229 overlapping peaks were flanked by high H3K4me3 levels, yet there was a small overlap of 230 binding in a short region with low H3K4me3 levels (Figure 4a ). DLL4 is another ligand of the 231 Notch receptor. We could only detect one Pax6 peak in the vicinity of its gene but it 232 overlapped with KDM5C in an H3K4-negative region of the gene, in contrast to a second 233 KDM5C-peak that overlapped with an H3K4me3-positive site but no Pax6 binding ( Figure  234 to analyze the effects of PAX6 /KDM5C knockdown (PAX6 siRNA (p=0.0005) and KDM5C 253 siRNA (p=0.0002)) on the expression levels of DLL1, DLL4, and HES1.
We did not detect any significant differences in the expression of HES1 after PAX6/KDM5C 256 RNA knockdown in hNPs compared to control (Figure 5) . As noted (Figure 4c) , the HES1 gene 257 region was very rich in H3K4me3, suggesting that PAX6/KDM5C may not be dominant 258
repressive regulators of the expression of this gene. When analyzing the expression of DLL1, 259
we found that the gene expression decreased (p=0,0040) after RNA knockdown of 260 PAX6/KDM5C in hNPs compared to control. 261 262 Lastly, we analyzed the gene expression levels of DLL4 after RNA knockdown of 263 PAX6/KDM5C in the hNPs, and found a robust increase (p=0,0020) in the mRNA levels 264 compared to control (Figure 5) . 265
266
In summary, our results demonstrate that there is a relatively small subset of 267 developmentally critical genes, including Notch signaling factors, co-occupied by PAX6 and 268 KDM5C on H3K4me3-negative regions, and that these two factors exert essential control of 269
proper expression of some of these genes. observations). It is likely that this has not been shown before due to the large number of 288 genes to which PAX6 is binding and directly regulating 31 , and it is not until analyzing the co-289 occupied regions with KDM5C that this subpopulation of genes is revealed. 290 291 PAX6 has previously been linked to chromatin modifying and remodeling factors, such as 292 CBP/p300 and members of the SWI/SNF and BAF complexes (cf. 44 , reviewed in 31 ). Less is 293 however known about the mechanisms underlying transcriptional repression by Pax6. Our 294 findings show that Pax6 and KDM5C co-occupy regions with low H3K4me3 but many peaks 295 of PAX6 found at regions with low H3K4me3 were not occupied by KDM5C and thus 296
presumably not active (Figure 3a) . Therefore, alternative mechanisms of repression should 297 be considered. It was recently shown that Pax6 binds to the histone deacetylase HDAC1 with 298 functional implications for lens development 36 . HDAC1 is however not ubiquitously 299 expressed in neural progenitors 11 , and in the hNPs used in the present study, another class I 300 HDAC, HDAC2, is the most prominently expressed (M. Lam and A. Falk, personal 301 communications). Class I HDACs such as HDAC1 and HDAC2 can be members of the so called 302 NURD complex that among other things regulate H3K27 acetylation, and indeed we found in 303 the transcriptional assays that PAX6 overexpression resulted in a decrease in H3K27 other class I HDACs and possibly the NURD complex in hNPs to regulate the H3K27 306 acetylation. 307 308 As demonstrated in Figure 5 , simultaneous RNA knockdown of PAX6 and KDM5C did not 309 result in an increased gene expression of all genes assessed. At a first glance, this may seem 310 like a contradiction, but the variations in the chromatin landscape surrounding the 311 PAX6/KDM5C binding sites must be taken into account. Thus, in the case of DLL1, there are 312 multiple PAX6 binding sites in the gene but only one overlapping peak with KDM5C ( Figure  313 4a). It may therefore be hypothesized that the decrease in DLL1 gene expression was a net 314 result by knocking down PAX6 not only as a repressor but also as an activator, and that PAX6 315 may be predominantly an activator of the DLL1 gene. Further, the chromatin landscape in 316 the vicinity of the PAX6/KDM5C binding site at the HES1 gene was very rich in H3K4me3 317 (Figure 4c) , pointing to an ancillary role for PAX6/KDM5C in the regulation of HES1 gene 318 expression. 319 320 When analyzing the transcriptional outcome, it should be noted that the chromatin is 321 organized in a 3-dimensional manner, and it is the nanoorganization -or nanoarchitecture -322 in coordination with the chemical milieu that will provide the optimal conditions for 323 transcriptional regulation. Such parameters are extremely dynamic, especially in progenitor 324 cells. A common model of the outcome of chromatin modifications is the "gas and brake" of 325 a car, where H3K4me3 is compared to the gas and H3K27me3 to the brake. The model is of 326 course knowingly a simplification, but staying with the car analogy, a simplified model for 327 transcriptional regulation by chromatin modifications could rather be compared to a 328 "clutch", as previously proposed 11 , where the state of transcription and nanoarchitecture 329 will influence the effect of changes in transcription and chromatin modifying factor levels. As 330 the surrounding chemical architecture will determine the overall transcriptional activity, the 331 effect(s) of simple RNA knockdown or overexpression will depend on the overall 332 enhancer/promoter activity, and the effects will be different depending on the baseline of 333 the transcription of the gene assessed, the number of transcription factor binding sites, the The generation of AF22, a control iPS cell line, has been described elsewhere 48 . Briefly, to 370 culture long-term self-renewing neuroepithelial-like stem cells or neural progenitors (hNPs), 371 hiPS cell colonies were induced to differentiate to neural tissue and hNPs cultures were 372 captured and maintained by passaging them at the ratio of 1:3 every third day essentially as 373 previously described 48 . Briefly, hNPs cultures were maintained in hNPs medium (DMEM/F-374 12, GlutaMAX containing N 2 supplement, FGF2 (10 ng ml −1 ), B27 (0.1%), Pen/Strep (all from 375 Invitrogen), and EGF (10 ng ml −1 ; Peprotech, Rocky Hill, NJ, USA)), and harvested using 376
TrypLE-Express (Gibco) for passage into 0.1 mg poly-L-ornithine (Sigma-Aldrich) and 377 1 μg ml −1 laminin L2020 (Sigma-Aldrich) coated (PLO/L-coated) plates at 1:3 ratio. We would like to thank members of the Hermanson lab for valuable input on the study. 
